Zacks Research Analysts Lower Earnings Estimates for ResMed
ResMed Inc. (NYSE:RMD – Free Report) – Zacks Research reduced their Q4 2026 earnings per share (EPS) estimates for shares of ResMed in a research note issued on Wednesday, February 19th. Zacks Research analyst R. Department now anticipates that the medical equipment provider will earn $2.48 per share for the quarter, down from their prior […]
ResMed Inc. (NYSE:RMD – Free Report) – Zacks Research reduced their Q4 2026 earnings per share (EPS) estimates for shares of ResMed in a research note issued on Wednesday, February 19th. Zacks Research analyst R. Department now anticipates that the medical equipment provider will earn $2.48 per share for the quarter, down from their prior […]
